Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 13/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 11/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22050655 | 0.84 | CYP17A1 (0.49) | ASIC3CYP19A1CYP17A1CYP3A4 | |
| SCHEMBL22862144 | 0.73 | MGLL (0.43) | CYP19A1CYP17A1CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL2202087 | 0.71 | ALDH1A1 (0.52) | CYP19A1CYP3A4NPC1ALDH1A1MAPT | |
| SCHEMBL2626828 | 0.67 | CYP3A4 (0.50) | CYP19A1HRH3CYP17A1CYP3A4ALDH1A1 | |
| SCHEMBL27617871 | 0.66 | — | — | |
| SCHEMBL19800933 | 0.66 | — | — | |
| SCHEMBL14415970 | 0.66 | HRH4 (0.44) | HRH3ALDH1A1HRH4 | |
| SCHEMBL8476034 | 0.66 | CYP19A1 (0.41) | CYP19A1CYP17A1CYP3A4ALDH1A1HRH4 | |
| SCHEMBL20869792 | 0.65 | ALDH1A1 (0.46) | CYP19A1CYP3A4NPC1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL25371613 | 0.64 | HRH4 (0.43) | HRH3ALDH1A1HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200172470-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172470-A1 | NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT | PAM, CBR1, KDM1A | ASIC3 1685/4885CYP19A1 117/4885HRH3 281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.